| 1. |
NZ academics say DTC advertising of Rx drugs should be banned |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 2. |
Health technology assessment: managing uncertainty |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 3-4
Mark Greener,,
Preview
|
|
摘要:
In an ideal world, cost-effectiveness analyses and health technology assessments would be based on perfect information. Unfortunately, we do not live in an ideal world. As a result, the UK's National Institute for Clinical Excellence (NICE), other health technology assessment organisations and regulatory bodies need to base their influential decisions on imperfect information. Fortunately, a recent meeting, entitled 'Optimal use of pharmacoeconomics throughout new product R&D: Improving pre-launch outcomes support planning and commercial decision-making', held in London, UK, in November 2002, heard that health economists have developed several means to tackle uncertainties.
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 3. |
The president of the British Association of Dermatologists has called for pharmacists to be able to prescribe effective drugs for skin disorders and infections, |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 4. |
Health interventions"very cost effective"in less-developed countries |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 5. |
Prescribing patterns for hypnosedatives are not influenced by gender alone, |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 6. |
IV PPI use warranted for GI haemorrhage in Canada |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 7. |
Resource use high in psychotic disorders in Australia |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 8. |
Camera-based screening for diabetic retinopathy well worth it in Canada |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 9. |
Racial disparities in antipsychotic prescribing? |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
| 10. |
The US FDA received a programme level budget of $US1.64 billion when the US President signed the FY2003 Omnibus Appropriation Bill in February this year, |
| |
PharmacoEconomics & Outcomes News Weekly,
Volume &NA;,
Issue 402,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-5503
出版商:ADIS
年代:2003
数据来源: ADIS
|
首页
